CRT 2026

VALVE COMPLICATIONS AND MANAGEMENT | SESSION ONE

Moderator(s)

• 

  Itsik Ben-Dor, MD

  WHC
  MedStar Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure(s): No financial relationships to disclose
• 

  Samir R. Kapadia, MD, FSCAI

  Chairman, Cardiovascular Medicine
  Cleveland Clinic
  Cleveland, Ohio, United States

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Rony Lahoud, MD

  Associate Professor
  University of Vermont
  S. Burlington, Vermont, United States

  Disclosure information not submitted.
• 

  Michael R. Mooney, MD, FACC, FAHA, FSCAI

  Director, Coronary Therapeutics
  Minneapolis Heart Institute at Abbott Northwestern Hospital
  Minneapolis, Minnesota, United States

  Disclosure(s): No financial relationships to disclose
• 

  Kamran Muhammad, MD

  Director, Structural Heart Disease Program; Co-director Cardiac Catheterization Laboratory
  Oklahoma Heart Institute at Hillcrest Medical Center
  Tulsa, Oklahoma, United States

  Disclosure information not submitted.
• 

  Mehul Patel, MD

  Director of SHD
  Methodist LeBonheur Healthcare
  Germantown, Tennessee, United States

  Disclosure(s): Xenter Inc: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Michael Ragosta, MD

  Interventional Cardiologist
  University of Virginia
  Charlottesville, Virginia, United States

  Disclosure(s): No financial relationships to disclose
• 

  Christian Shults, MD

  Cardiac Surgeon
  MedStar Heart and Vascular Institute
  Washington, District of Columbia, United States

  Disclosure information not submitted.
• 

  Steven J. Yakubov, MD, FACC, MSCAI

  System/Medical Chief - Structural Heart Disease
  OhioHealth/Riverside Methodist Hospital
  Columbus, Ohio, United States

  Disclosure information not submitted.